Stock fact sheet · data as of

Nuveen Real Asset Income and Growth Fund (JRI): fair value, margin of safety and Wheel Score

Financial Services · Asset Management - Income · United States · High Yield Income

Close10.48
GLS fair value30.409 of 9 models
Margin of safety+66%price below fair value
Wheel Score39No optionscapped: no options
Health6/9Piotroski F-score
Moat2.6/10GLS 10-year score
Market cap$288M246k shares a day
Implied vol.-no listed options
P/E7.2EPS 1.46
Dividend yield15.29%payout 87%
Beta0.90about the market
Next earnings-no date recorded

Is JRI undervalued?

At 10.48 (close of 16 Oct 2026), JRI trades 66% below the GLS average fair value of 30.40. That average comes from 9 models run on the latest filings, and 9 of them land above the current price. Margins of safety over 30% are the exception rather than the rule across the ~7,400 stocks we value each night, so the number earns Nuveen Real Asset Income and Growth Fund the full Value points in the Wheel Score - and a closer look at what the market is pricing in.

There is a wide gap between DCF (10.52) and Graham Growth (83.49). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files JRI under High Yield Income: a dividend yield above 4%.

Nine valuation models for JRI

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF10.52+0%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number21.00+100%The most a defensive investor pays for the earnings and book value per share
Graham Growth83.49+697%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch36.49+248%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth48.72+365%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap12.76+22%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time20.79+98%Eight years of compounded free cash flow: the price at which the business pays for itself
DDM23.57+125%Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend
EPV16.22+55%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)-5.88-156%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Nuveen Real Asset Income and Growth Fund scores 6 of 9 on the Piotroski F-score: a middling result that passes the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. A GLS Moat score of 2.6/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are moderate - ROIC 9.1%, ROE 13.4%, ROA 9.0% - with debt at 0.47 times equity and a free-cash-flow yield of 8.0%.

The dividend yield is high at 15.29% (payout ratio 87%). A yield this size is often the market's way of pricing a risk to the payout, so the health score and cash flow matter more than usual.

Institutional ownership scores 5/10, insider activity 10/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score6 / 9ROIC9.1%
GLS Moat2.6 / 10ROE13.4%
Debt / equity0.47ROA9.0%
Free-cash-flow yield8.0%Payout ratio87%
Institutions5 / 10Insiders · Congress10 · 5 / 10

Wheel Score 39: No options

No options are listed on Nuveen Real Asset Income and Growth Fund in our nightly snapshot. The Wheel Score is therefore capped at 39 (it reads 39) and the stock is left out of every options screen; the fair value and health figures above are still useful for a plain stock position.

Volume runs at 246k shares a day on a market cap of $288M, with a beta of 0.90; the Stability part of the Wheel Score gives that 8 of 20.

PartPointsFrom
Value25 / 2566% margin of safety
Health13 / 20Piotroski 6/9
Moat4 / 15moat 2.6/10
Premium0 / 20no option data
Stability8 / 20246k shares/day, $288M cap, beta 0.90

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for JRI in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Asset Management - Income

The 12 companies below are the closest to Nuveen Real Asset Income and Growth Fund by market cap within the Asset Management - Income industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
AIHAX
Horizon Active Income Fund - Advisor Class
7.734.89-58%17No options$286M
XFLT
XAI Octagon Floating Rate & Alternative Income Term Trust
18.7441.78+55%39No options$285M
TEI
Templeton Emerging Markets Income Fund
6.1536.59+83%39No options$290M
EFT
Eaton Vance Floating-Rate Income Trust
10.6312.80+17%39No options$283M
HPF
John Hancock Preferred Income Fund II
12.9824.81+48%39No options$281M
PFCOX
PFG American Funds Cons Inc Strat R
9.8011.76+17%39No options$278M
BRW
Saba Capital Income & Opportunities Fund
5.9118.88+69%39No options$301M
BGT
BlackRock Floating Rate Income Trust
10.0925.67+61%39No options$301M
OIA
Invesco Municipal Income Opportunities Trust
5.764.97-16%30No options$275M
FINS
Angel Oak Financial Strategies Income Term Trust
12.1250.29+76%39No options$304M
NXG
NXG NextGen Infrastructure Income Fund
52.50684.35+92%39No options$304M
NCZ
Virtus Convertible & Income Fund II
13.97108.62+87%39No options$266M

⚖ Compare JRI with 7 of them   All Financial Services stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about JRI

Is JRI undervalued right now?

By the GLS models, yes: at 10.48 the stock is 66% below the average fair value of 30.40 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.

What is the Wheel Score of JRI and what does it mean?

JRI has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for JRI?

30.40 per share as of 16 Oct 2026 - the simple average of the 9 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Nuveen Real Asset Income and Growth Fund report earnings next?

No upcoming earnings date is recorded for JRI in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.

Does JRI have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on JRI, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.